16 news release. Until Kisqali, only breast cancerdrug Verzenio was approved to reduce the risk of patients with early breast cancer, although it was available only to patients with a very ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said ...